|
Biogen Idec to share latest neurology data at AAN 2014
Zenopa Further information will be shared on products such as Tysabri, Avonex, Fampyra, Anti-LINGO-1 and daclizumab high-yield process. Dr Alfred Sandrock, group senior vice-president and chief medical officer at Biogen Idec, said: “The breadth of data we are … |
Brampton woman denied OHIP coverage for life-saving cancer drugs – Caledon Enterprise
|
Brampton woman denied OHIP coverage for life-saving cancer drugs
Caledon Enterprise The other drug, Rituximab, is approved for second line use, but only in tandem with Fludarabine — a drug that Mitchell can’t take because she suffered an extreme, adverse reaction to it during her first bout with chemotherapy. “The drugs that my … |
Is Biogen A Value Stock Yet? – Seeking Alpha
|
Is Biogen A Value Stock Yet?
Seeking Alpha Daclizumab is being developed under a collaboration agreement with Abbvie Biotherapeutics. X. X. X. GA101 (HUMANIZED ANTI-CD20 MAB) Non-Hodgkin’s Lymphoma. Humanized monoclonal antibody specific for CD20. Humanized anti-CD20 mAb is … Biogen Idec to share latest neurology data at AAN 2014Zenopa |
Vietnam uses stem cell transplant to treat cerebral palsy – Thanh Nien Daily
Thanh Nien Daily |
Vietnam uses stem cell transplant to treat cerebral palsy
Thanh Nien Daily He told Phu Nu that international researches have suggested the successful chance of stem cell transplant in treating cerebral palsy at 60-70 percent. The approach has been found to be most effective in recovering one’s mobility, followed by language … |
REVIVE-IT heart failure study resumes after safety modification – University of Michigan Health System News (press release)
REVIVE-IT heart failure study resumes after safety modificationUniversity of Michigan Health System News (press release)ANN ARBOR, Mich. — The University of Michigan Health System, received approval from the Food and Drug Administration (FDA) on March…
New Approach to Protecting Heart Failure Patients – UConn Advance (blog)
UConn Advance (blog)New Approach to Protecting Heart Failure PatientsUConn Advance (blog)Dr. Bruce Liang, director of the Pat and Jim Calhoun Cardiology Center and chief of the division of cardiology, writes in the journal Circulation about a mechanism…
Brampton woman denied OHIP coverage for life-saving cancer drugs – Mississauga
|
Brampton woman denied OHIP coverage for life-saving cancer drugs
Mississauga The other drug, Rituximab, is approved for second line use, but only in tandem with Fludarabine — a drug that Mitchell can’t take because she suffered an extreme, adverse reaction to it during her first bout with chemotherapy. “The drugs that my … |
5 memorable Guinness records broken by PH brands – Marketing Interactive
|
5 memorable Guinness records broken by PH brands
Marketing Interactive The Department of Health and the Polytechnic University of the Philippines broke India’s record for the most organ donation pledges in one hour in a single site in February 2014. Part of the agency’s “I’m a Lifeline” campaign, it got 3,548 pledges … |
VisitandCare.com Offers Streamlined Approach to Top Medical Tourism … – PR Web (press release)
VisitandCare.com Offers Streamlined Approach to Top Medical Tourism …PR Web (press release)Hair Transplant Surgery | Premier hair restoration surgeons are offering hair transplantation solutions to the 80 million men and women experiencing hair loss….
The French woman who gifted three lives – The Hindu
The HinduThe French woman who gifted three livesThe HinduAs for the liver, it went to a 38-year-old serving soldier in the Indian Army who needed an urgent transplant. While his wife was keen to donate, her vital parameters had not matched and there wa…